Fresenius Medical Care Stock Current Asset
| FMS Stock | USD 22.56 0.40 1.81% |
Fresenius Medical Care fundamentals help investors to digest information that contributes to Fresenius Medical's financial success or failures. It also enables traders to predict the movement of Fresenius Stock. The fundamental analysis module provides a way to measure Fresenius Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fresenius Medical stock.
Other Current Assets is likely to gain to about 1.4 B in 2024, whereas Non Current Assets Total are likely to drop slightly above 13.8 B in 2024. Fresenius | Current Asset |
Fresenius Medical Care Company Current Asset Analysis
Fresenius Medical's Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Fresenius Medical Current Asset | 6.98 B |
Most of Fresenius Medical's fundamental indicators, such as Current Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fresenius Medical Care is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Fresenius Current Asset Historical Pattern
Today, most investors in Fresenius Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Fresenius Medical's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's current asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Fresenius Medical current asset as a starting point in their analysis.
Fresenius Medical Current Asset |
| Timeline |
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.
| Competition |
Fresenius Total Assets
Total Assets |
|
In accordance with the recently published financial statements, Fresenius Medical Care has a Current Asset of 6.98 B. This is 224.58% higher than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current asset for all United States stocks is 25.2% higher than that of the company.
Fresenius Current Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fresenius Medical's direct or indirect competition against its Current Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Fresenius Medical could also be used in its relative valuation, which is a method of valuing Fresenius Medical by comparing valuation metrics of similar companies.Fresenius Medical is currently under evaluation in current asset category among its peers.
Fresenius Medical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Fresenius Medical from analyzing Fresenius Medical's financial statements. These drivers represent accounts that assess Fresenius Medical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Fresenius Medical's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 9.9B | 10.0B | 8.4B | 4.5B | 5.6B | 9.1B | |
| Enterprise Value | 22.7B | 21.3B | 20.2B | 16.4B | 16.3B | 13.9B |
Fresenius Medical ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Fresenius Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Fresenius Medical's managers, analysts, and investors.Environmental | Governance | Social |
Fresenius Fundamentals
| Return On Equity | 0.0582 | ||||
| Return On Asset | 0.0298 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.08 % | ||||
| Current Valuation | 24.17 B | ||||
| Shares Outstanding | 586.83 M | ||||
| Shares Owned By Institutions | 7.40 % | ||||
| Number Of Shares Shorted | 730.18 K | ||||
| Price To Earning | 6.53 X | ||||
| Price To Book | 0.92 X | ||||
| Price To Sales | 0.68 X | ||||
| Revenue | 19.45 B | ||||
| Gross Profit | 5.31 B | ||||
| EBITDA | 3.21 B | ||||
| Net Income | 732.46 M | ||||
| Cash And Equivalents | 362.77 M | ||||
| Cash Per Share | 1.75 X | ||||
| Total Debt | 12.05 B | ||||
| Debt To Equity | 0.88 % | ||||
| Current Ratio | 1.18 X | ||||
| Book Value Per Share | 46.43 X | ||||
| Cash Flow From Operations | 2.63 B | ||||
| Short Ratio | 3.75 X | ||||
| Earnings Per Share | 1.18 X | ||||
| Price To Earnings To Growth | 0.45 X | ||||
| Target Price | 21.15 | ||||
| Number Of Employees | 113.08 K | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 13 B | ||||
| Total Asset | 33.93 B | ||||
| Retained Earnings | 10.92 B | ||||
| Working Capital | 2.59 B | ||||
| Current Asset | 6.98 B | ||||
| Current Liabilities | 4.19 B | ||||
| Annual Yield | 0.03 % | ||||
| Five Year Return | 1.29 % | ||||
| Net Asset | 33.93 B | ||||
| Last Dividend Paid | 1.19 |
About Fresenius Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fresenius Medical Care's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fresenius Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fresenius Medical Care based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.